Fig. 1From: Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signaturePerformance comparison of therapy response models with 95% confidence intervals. MV multi-view, MVS multi-view score, TSC transcriptomics, TSCS transcriptomic score, RAD radiomics, RADS radiomic score, DL deep learning, DLS deep learning scoreBack to article page